Decreased serum CA19-9 is associated with improvement of insulin resistance and metabolic control in patients with obesity and type 2 diabetes after Roux-en-Y gastric bypass

AIMS/INTRODUCTION: Patients with type 2 diabetes are known to show elevated serum levels of carbohydrate antigen 19-9 (CA19-9). The aim of the present study was to investigate the possible relationships of CA19-9 with metabolic control, insulin resistance (IR), and pancreatic β-cell function in pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Yinfang, Yu, Haoyong, Zhang, Pin, Di, Jianzhong, Han, Xiaodong, Wu, Songhua, Bao, Yuqian, Jia, Weiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234233/
https://www.ncbi.nlm.nih.gov/pubmed/25422770
http://dx.doi.org/10.1111/jdi.12200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234233/
https://www.ncbi.nlm.nih.gov/pubmed/25422770
http://dx.doi.org/10.1111/jdi.12200

Ejemplares similares